(Q51444739)

5 April 2018

title

Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years. (English)

1 reference

5 April 2018

0 references

2

1 reference

5 April 2018

author name string

Maria Nordwall

series ordinal

1

1 reference

5 April 2018

publication date

1 September 2008

1 reference

5 April 2018

Diabetes - Metabolism: Research and Reviews

published in

1 reference

5 April 2018

volume

24

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

472-479

1 reference

5 April 2018

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

cites work

1 reference

Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents

21 January 2018

1 reference

Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes

21 January 2018

1 reference

Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in Northern than in Southern Europe

21 January 2018

1 reference

7 January 2021

Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes

1 reference

7 January 2021

Clinical characteristics at onset of Type 1 diabetes in children diagnosed between 1977 and 2001 in the south-east region of Sweden

1 reference

7 January 2021

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control

1 reference

7 January 2021

Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas

1 reference

7 January 2021

Metabolic control in newly diagnosed type 1 diabetic children. Effect of continuous subcutaneous infusion

1 reference

7 January 2021

Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial

1 reference

7 January 2021

Sustained normoglycemia and remission phase in newly diagnosed type I diabetic subjects. Comparison between continuous subcutaneous insulin infusion and conventional therapy during a one year follow-up.

1 reference

7 January 2021

Sustained normoglycemia in newly diagnosed type I diabetic subjects. Short-term effects and one-year follow-up.

1 reference

7 January 2021

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

1 reference

7 January 2021

Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

1 reference

7 January 2021

Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study

1 reference

7 January 2021

Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial

1 reference

7 January 2021

Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes

1 reference

7 January 2021

Establishing a standard definition for child overweight and obesity worldwide: international survey

1 reference

7 January 2021

A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10

1 reference

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

7 January 2021

Analysis of serial measurements in medical research

1 reference

7 January 2021

Comparisons of studies on diabetic complications hampered by differences in GHb measurements

1 reference

7 January 2021

Radioimmunological determination of human C-peptide in serum

1 reference

7 January 2021

Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.

1 reference

7 January 2021

Clinical and laboratory features of type 1 diabetic children at the time of diagnosis.

1 reference

7 January 2021

Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group

1 reference

7 January 2021

Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group

1 reference

7 January 2021

Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM.

1 reference

7 January 2021

Postinitial remission in diabetic children--an analysis of 178 cases

1 reference

7 January 2021

Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study.

1 reference

7 January 2021

Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis

1 reference

7 January 2021

Factors predicting course of beta-cell function in IDDM

1 reference

7 January 2021

Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children

1 reference

7 January 2021

The severity of clinical presentation of type 1 diabetes in children does not significantly influence the pattern of residual beta-cell function and long-term metabolic control

1 reference

7 January 2021

Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.

1 reference

7 January 2021

Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.

1 reference

7 January 2021

Standard breakfast test: an alternative to glucagon testing for C-peptide reserve?

1 reference

7 January 2021

Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve

1 reference

7 January 2021

5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control

1 reference

7 January 2021

The epidemiology of lost residual beta-cell function in short term diabetic children

1 reference

7 January 2021

Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden

1 reference

7 January 2021

Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.871

1 reference

5 April 2018

1 reference

5 April 2018